• Sanket Kalyan Langore
• Mayur Kisan Kolhatkar
• Prof. Gaurav Wadurkar
• Dr. KALYAN R. LANGORE

Chronic obstructive pulmonary disease (COPD) is a significant and increasing burden worldwide. Classically, COPD was considered only as a respiratory disease mainly caused by smoking. However, COPD has important extrapulmonary manifestations, or so-called systemic effects. These include unintended weight loss, skeletal muscle dysfunction, increased risk of cardiovascular disease, osteoporosis and depression. Low-grade chronic systemic inflammation is one of the main mechanisms of these systemic effects. Because these extrapulmonary manifestations of COPD are common and/or can significantly affect patient well-being and prognosis, they require systematic screening and appropriate treatment to provide optimal medical care.

Copd, pharmacology

"RIVIEW ARTICLE ON SYSTEMIC EFFECT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 12, page no.c311-c319, December-2022, Available :http://www.jetir.org/papers/JETIR2212247.pdf

"RIVIEW ARTICLE ON SYSTEMIC EFFECT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 12, page no. ppc311-c319, December-2022, Available at : http://www.jetir.org/papers/JETIR2212247.pdf